Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.
Batch number on every vial
Published Certificates of Analysis
Purity verified by third-party testing
Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.
GHRP-2 (10mg) is a synthetic hexapeptide classified as a growth hormone secretagogue. Originally developed as an analogue of met-enkephalin, it is widely used in endocrine and metabolic research. In laboratory studies, GHRP-2 has been investigated for its ability to stimulate growth hormone release by activating specific secretagogue pathways.
Early studies demonstrated that administering GHRP-2 can increase pulsatile growth hormone secretion and influence downstream factors, such as insulin-like growth factor-1 (IGF-1), in controlled research settings.
For laboratory research use only.
GHRP-2 has been studied as a tool for examining the regulation of growth hormone release and related endocrine processes. In laboratory models, the peptide has been investigated for its role in stimulating growth hormone secretion and influencing downstream signaling pathways associated with metabolism and cellular growth.
In endocrinology research, GHRP-2 has been used to evaluate the function of the hypothalamic-pituitary axis. Experiments have measured hormone responses following peptide administration, allowing researchers to observe changes in growth hormone, adrenocorticotropic hormone (ACTH), and cortisol levels under experimental conditions.
Additional studies have explored GHRP-2’s potential in metabolic and cardiovascular research, focusing on its effects on oxidative stress, inflammatory signaling, and lipid-related pathways in cell cultures and animal models.
In clinical endocrine testing, a typical experimental protocol involves administering a single intravenous dose of approximately 100 µg of GHRP-2 to evaluate hormonal responses. Blood samples collected during the monitoring period are used to measure changes in growth hormone, ACTH, and cortisol levels in research settings related to hypothalamic-pituitary disorders.
Animal studies have investigated GHRP-2 in metabolic and cardiovascular models. In one study with ApoE-deficient mice, repeated GHRP-2 administration at microgram doses increased circulating IGF-1 levels and reduced oxidative stress markers in vascular tissue. However, these findings were observed under controlled experimental conditions and should not be interpreted as evidence of validated clinical outcomes.
Cell-based research has examined GHRP-2’s effects on oxidative stress and cellular signaling. Experiments with vascular smooth-muscle cells and macrophages reported reductions in reactive oxygen species production and changes in lipid-handling pathways when the peptide was introduced into the culture environment.
These findings support GHRP-2’s continued use as a research tool for studying endocrine and metabolic mechanisms.
Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
Subscribe for exclusive offers and updates on new arrivals